Axcella’s next steps in developing its pipeline of product candidates include a phase 2b trial of AXA1125 ... including those measuring liver fat (MRI-PDFF) and insulin resistance (HOMA-IR ...

Recent advancements in liver imaging, particularly the use of hepatocyte ... These nodules, especially those hypointense in the hepatobiliary phase (HBP) without arterial phase hyperenhancement ...